RIVN Financial Statements & Analysis
Complete financial statements for RIVN including income statement, balance sheet, and cash flow statement. Analyze RIVN's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
65
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
12.1% ↑
Net Income
12.6% ↑
Gross Margin
47.3% ↑
Operating Margin
27.1% ↑
Balance Sheet
Current Ratio
-5.0% ↓
Debt to Equity
41.7% ↓
Asset Turnover
22.0% ↑
Cash Flow
Operating Cash Flow
64.7% ↑
Net Cash Flow
39.6% ↑
Free Cash Flow
51.5% ↑
Cash Flow to Debt
65.3% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 4.43B | 4.97B | 12.1% | |
| Gross Profit | -2030000000 | -1200000000 | 40.9% | |
| Operating Income | -5739000000 | -4689000000 | 18.3% | |
| Net Income | -5432000000 | -4747000000 | 12.6% | |
| EPS | -5.74 | -4.69 | 18.3% | |
| EBITDA | -4274000000 | -3392000000 | 20.6% | |
| Gross Margin | -45.78% | -24.14% | 47.3% | |
| Operating Margin | -129.43% | -94.35% | 27.1% | |
| Net Income Margin | -122.51% | -95.51% | 22.0% | |
| R&D Expenses | 2.00B | 1.61B | 19.1% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.97B | 4.43B | 1.66B | 55.00M | 0 |
| Gross Profit | -1200000000 | -2030000000 | -3123000000 | -465000000 | -29000000 |
| Operating Income | -4689000000 | -5739000000 | -6856000000 | -4220000000 | -1021000000 |
| Net Income | -4747000000 | -5432000000 | -6752000000 | -4716000000 | -1027000000 |
| EPS | -4.69 | -5.74 | -7.4 | -5.24 | -1.14 |
| EBITDA | -3392000000 | -4274000000 | -5993000000 | -4462000000 | -992000000 |
| Gross Margin | -24.14% | -45.78% | -188.36% | -845.45% | 0.00% |
| Operating Margin | -94.35% | -129.43% | -413.51% | -7672.73% | 0.00% |
| Net Income Margin | -95.51% | -122.51% | -407.24% | -8574.55% | 0.00% |
| R&D Expenses | 1.61B | 2.00B | 1.94B | 1.85B | 766.00M |